Atlas Trials

Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells

Clinical trial NCT06586658 · SUSPENDED

Trial details

NCT number
NCT06586658
Sponsor
Shanghai Changzheng Hospital
Status
SUSPENDED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2024-09-06
Primary completion
2027-07-16
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.